Skip to content

The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.

To Investigate the Headache Induction and the Cerebral Hemodynamic Changes After Infusion of Adenosine in Healthy Volunteers and Migraine Patient

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04577443
Enrollment
18
Registered
2020-10-08
Start date
2020-11-01
Completion date
2021-10-30
Last updated
2022-11-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Headache, Migraine

Brief summary

Adenosine is a nucleoside that plays a role in both vascular and nociceptive systems, and it has been proposed that adenosine may cause headache in particularly sensitive subjects. Thus, considerable evidence implied that adenosine plays a role in migraine pathophysiology, it is still unknown if intravenous adenosine infusion provokes migraine attacks in healthy subject or in migraine patients. Furthermore, adenosine's effects on the cerebral hemodynamic remains unknown. This study aims to clarify a possible coherence between adenosine and headache/migraine. In general, the study will contribute to a greater understanding of migraine pathogenesis and possibly lead to development of specific migraine treatment.

Interventions

DRUGAdenosine

To investigate the role of adenosine on cerebral hemodynamic and headache in healthy volunteers and migraine patients

DRUGSaline

To investigate the role of saline on cerebral hemodynamic and headache in healthy volunteers and migraine patients

Sponsors

Danish Headache Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Migraine patients without aura who fulfill criteria in the international classification of headaches. This does not apply to healthy volunteers. * 18-60 years. * 50-90 kg. * Women of childbearing potential must use adequate contraception

Exclusion criteria

* Headache less than 48 hours before the tests start * All primary headaches, except migraine without aura for migraine patients, according to international classification of headache * Daily consumption of drugs of any kind other than oral contraceptives * Pregnant or nursing women. * Cardiovascular disease of any kind, including cerebrovascular diseases.

Design outcomes

Primary

MeasureTime frameDescription
Occurrence and change of migraine attackBefore (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of salineOccurrence and of migraine according to international criteria

Secondary

MeasureTime frameDescription
Change in cerebral hemodynamicBefore (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of salineChange on velocity of media cerebri artery.
Occurrence and change of headacheBefore (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of salineOccurrence of headache measured by numerical rating scale (NRS)
Change of diameter of the arteryBefore (-10 minutes) and after infusion (+12 hours) of adenosine compared with before and after infusion of salineChange of diameter of superficial temporal artery and radial artery. The diameter will be measured by millimeter (mm).

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026